PAOG Expands Reach Into $100 Billion Medical Cannabis Market
Sandusky, OH -- July 21, 2020 --
InvestorsHub NewsWire -- PAO Group, Inc. (USOTC:
PAOG) today published additional information following the
management takeover and cannabis strategy revitalization
strategy announcement last week. James, C. DiPrima, the
current Chief Executive Officer (CEO), and a team of managers have
purchased control of PAOG in conjunction with a plan to make two
acquisitions intended to reinvigorate and accelerate PAOG’s mission
to provide medical cannabis patient care alternatives to
traditional patient care solutions. Today, the company is
providing additional information on next steps and the timing of
next steps.
PAOG plans first executing the acquisition
of a cannabis cultivation operation from Puration, Inc. (USTOC:
PURA). Next, PAOG plans to execute the acquisition of a
patented cannabis extraction operation from Kali-Extracts, Inc.
(USOTC:
KALY). Both acquisitions are expected to be closed by the
end of July.
Simultaneously, PAOG is updating its
public disclosures. The updates will be filed with OTC
Markets Group. PAOG’s intention is to achieve OTC Markets
Group’s Current Information
standard.
PAOG is also working to launch an all new
website that reflects its revitalization plan to include more
information on the two pending
acquisitions.
$100 Billion Medical Cannabis
Market
According to a report from Fortune Business Insights, the legal marijuana
market cannabis was over $10 billion in 2018 and the medical
cannabis sector is expected to reach almost $100 billion by
2027.
Patented
Cannabis Extraction
Operation
The patented
cannabis extraction operation is housed under NCM Biotech which is
focused on medical research and the development of treatments
derived from its patented cannabis extraction process. See a recent
research report on CBD extracts derived from NCM Biotech's patented
extraction process: Journal of Cannabis
Research.
Cannabis
Cultivation
Operation
PURA’s cannabis
cultivation operation is thriving, has revenue, and has recently
purchased and relocated to a new property from its former leased
property. Texas lawmakers have recently implemented hemp
friendly farming regulations and in so doing, universities within
the State of Texas have initiated hemp farming research
programs. PURA's cannabis cultivation spinoff has initiated a
number of joint research applications
with Texas universities.
PURA had
previously spun-off its cannabis cultivation operation to Nouveau
(USOTC:
NOUV) and is now unwinding that deal to move forward with
PAOG.
Forward-Looking
Statements: Certain statements in this news release may contain
forward-looking information within the meaning of Rule 175 under
the Securities Act of 1933 and Rule 3b-6 under the Securities
Exchange Act of 1934, and are subject to the safe harbor created by
those rules. All statements, other than statements of fact,
included in this release, including, without limitation, statements
regarding potential future plans and objectives of the company are
forward-looking statements that involve risks and uncertainties.
There can be no assurance that such statements will prove to be
accurate and actual results and future events could differ
materially from those anticipated in such statements. Technical
complications, which may arise, could prevent the prompt
implementation of any strategically significant plan(s) outlined
above. The Company undertakes no duty to revise or update any
forward-looking statements to reflect events or circumstances after
the date of this release.
CONTACT
INFORMATION
Contact Us:
Jim DiPrima
888-272-6472
info@pao.group
Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
過去 株価チャート
から 11 2024 まで 12 2024
Nouveau Life Pharmaceuti... (PK) (USOTC:NOUV)
過去 株価チャート
から 12 2023 まで 12 2024
Real-Time news about Nouveau Life Pharmaceuticals Inc (PK) (その他OTC): 0 recent articles
その他のNouveau Life Pharmaceuticals Inc (PK)ニュース記事